Stock News
Cancer Vaccine With 97% Complete Response Rate In Mice Starts Human Trials
A new cancer vaccine trial is now underway, as of March 27th, that is fundamentally different from any cancer vaccine trial held until now. Not only is it different, but it’s also a lot simpler, […]